Fortress Biotech Inc
F:CNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
S
|
Shiseido Co Ltd
XMUN:SHD
|
JP |
|
Stellantis NV
PAR:STLAP
|
NL |
|
E
|
Electronic Arts Inc
DUS:ERT
|
US |
|
Impala Platinum Holdings Ltd
F:IPHB
|
ZA |
|
Anglo American Platinum Ltd
F:RPH1
|
ZA |
|
N
|
Nomura Holdings Inc
XBER:NSE
|
JP |
|
A
|
Asahi Kasei Corp
XMUN:ASAA
|
JP |
|
S
|
Sonoco Products Co
F:SNS
|
US |
|
I
|
Impala Platinum Holdings Ltd
XBER:IPHB
|
ZA |
|
PKSHA Technology Inc
F:762
|
JP |
|
O
|
ON Semiconductor Corp
XMUN:XS4
|
US |
|
PTC Therapeutics Inc
F:BH3
|
US |
|
D
|
D'Ieteren Group NV
DUS:DJDA
|
BE |
Wall St Price Targets
CNB Price Targets Summary
Fortress Biotech Inc
According to Wall Street analysts, the average 1-year price target for
CNB is 14.761 EUR with a low forecast of 6.644 EUR and a high forecast of 23.484 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CNB's stock price target?
Price Target
14.761
EUR
According to Wall Street analysts, the average 1-year price target for
CNB is 14.761 EUR with a low forecast of 6.644 EUR and a high forecast of 23.484 EUR.
What is the Revenue forecast for Fortress Biotech Inc?
Projected CAGR
47%
The compound annual growth rate for Revenue over the next 2 years is 47%.
What is the Gross Profit forecast for Fortress Biotech Inc?
Projected CAGR
63%
The compound annual growth rate for Gross Profit over the next 2 years is 63%.